SG11201405559TA - Component and method for treating viral disease - Google Patents
Component and method for treating viral diseaseInfo
- Publication number
- SG11201405559TA SG11201405559TA SG11201405559TA SG11201405559TA SG11201405559TA SG 11201405559T A SG11201405559T A SG 11201405559TA SG 11201405559T A SG11201405559T A SG 11201405559TA SG 11201405559T A SG11201405559T A SG 11201405559TA SG 11201405559T A SG11201405559T A SG 11201405559TA
- Authority
- SG
- Singapore
- Prior art keywords
- component
- viral disease
- treating viral
- treating
- disease
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210062620 | 2012-03-09 | ||
| PCT/CN2013/072402 WO2013131496A1 (en) | 2012-03-09 | 2013-03-11 | Component and method for treating viral disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201405559TA true SG11201405559TA (en) | 2014-11-27 |
Family
ID=49115954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201405559TA SG11201405559TA (en) | 2012-03-09 | 2013-03-11 | Component and method for treating viral disease |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9872875B2 (en) |
| EP (1) | EP2875829A4 (en) |
| JP (1) | JP6116596B2 (en) |
| KR (1) | KR20150005526A (en) |
| CN (1) | CN103301462B (en) |
| IN (1) | IN2014DN08266A (en) |
| MY (1) | MY169687A (en) |
| SG (1) | SG11201405559TA (en) |
| WO (1) | WO2013131496A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108014341A (en) * | 2017-12-28 | 2018-05-11 | 南京东诺医药科技开发有限责任公司 | Anti-inflammatory composition and its application |
| CN110064044B (en) * | 2018-01-20 | 2022-09-09 | 中国科学院武汉病毒研究所 | Enterovirus 71 inhibitor and application thereof |
| CN108685888A (en) * | 2018-05-24 | 2018-10-23 | 南方医科大学 | Applications of the NF023 in preparation multiple-effect microbicide and HIV spread through sex intercourse blocking agent |
| CN108553472A (en) * | 2018-05-24 | 2018-09-21 | 南方医科大学 | Applications of the NF546 in preparation multiple-effect microbicide and HIV spread through sex intercourse blocking agent |
| CN115211402A (en) * | 2022-07-07 | 2022-10-21 | 中国医学科学院医学生物学研究所 | Construction method and use of a rodent model of CV-B3 infection |
| CN116115595B (en) * | 2022-11-25 | 2024-10-29 | 华中农业大学 | Application of Suramin in the prevention and treatment of carp spring viremia virus (SVCV) infection |
| CN119523959A (en) * | 2024-12-05 | 2025-02-28 | 西安交通大学 | Pharmaceutical use of P2Y11 specific inhibitors and compositions containing the same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6280928B1 (en) * | 1998-04-24 | 2001-08-28 | Diagnostic Hybrids, Inc. | Mixed cell diagnostic systems |
| ES2223287B1 (en) * | 2003-08-04 | 2006-04-16 | Universidad Del Pais Vasco-Euskal Herriko Unibertsitatea | COMPOUNDS FOR THE TREATMENT OF DEMIELINIZING AND AUTOIMMUNE DISEASES. |
| HUP0500145A2 (en) * | 2005-01-28 | 2006-11-28 | Gene Res Lab N | Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for preparation of medicaments against oral diseases |
| US20100292295A1 (en) | 2007-12-18 | 2010-11-18 | Glaxo Group Limited | 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators |
| CN101780278B (en) * | 2009-09-29 | 2012-02-01 | 福尔生物制药股份有限公司 | Bivalent hand-foot-and-mouth disease inactivated vaccine |
| CN101695569A (en) | 2009-11-03 | 2010-04-21 | 中国人民解放军军事医学科学院微生物流行病研究所 | Univalent and bivalent gene engineered subunit vaccine for hand-foot-and-mouth disease and preparation method thereof |
| US8710079B2 (en) | 2010-04-23 | 2014-04-29 | National Health Research Institutes | Quinoline compounds and their use for treating viral infection |
| US9051361B2 (en) * | 2010-08-17 | 2015-06-09 | National Health Research Institutes | Immunogenic compositions and uses thereof |
| CN102178678B (en) * | 2011-03-18 | 2012-12-19 | 中国医学科学院医学实验动物研究所 | Application of lycorine in preparing medicament for treating diseases caused by human enterovirus 71 type infection |
-
2013
- 2013-03-11 EP EP13757343.2A patent/EP2875829A4/en not_active Withdrawn
- 2013-03-11 US US14/384,075 patent/US9872875B2/en active Active
- 2013-03-11 IN IN8266DEN2014 patent/IN2014DN08266A/en unknown
- 2013-03-11 JP JP2014560239A patent/JP6116596B2/en active Active
- 2013-03-11 SG SG11201405559TA patent/SG11201405559TA/en unknown
- 2013-03-11 MY MYPI2014002589A patent/MY169687A/en unknown
- 2013-03-11 KR KR1020147027450A patent/KR20150005526A/en not_active Ceased
- 2013-03-11 WO PCT/CN2013/072402 patent/WO2013131496A1/en not_active Ceased
- 2013-03-11 CN CN201310077649.9A patent/CN103301462B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2875829A4 (en) | 2015-12-02 |
| EP2875829A1 (en) | 2015-05-27 |
| KR20150005526A (en) | 2015-01-14 |
| CN103301462A (en) | 2013-09-18 |
| JP2015510870A (en) | 2015-04-13 |
| WO2013131496A1 (en) | 2013-09-12 |
| JP6116596B2 (en) | 2017-04-19 |
| US9872875B2 (en) | 2018-01-23 |
| CN103301462B (en) | 2015-06-03 |
| IN2014DN08266A (en) | 2015-05-15 |
| MY169687A (en) | 2019-05-13 |
| US20150045318A1 (en) | 2015-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL235062A0 (en) | Compounds and methods for antiviral treatment | |
| EP2757887A4 (en) | Pyrrolopyridinone compounds and methods for treating hiv | |
| GB2500915B (en) | Arrangement and method | |
| IL238416A0 (en) | Compositions and methods for treating proteinopathies | |
| DK3292875T3 (en) | Compositions and methods for treating diseases | |
| ZA201501752B (en) | Methods for treating hepatitis c | |
| ZA201501758B (en) | Methods for treating hepatitis c | |
| SG11201405559TA (en) | Component and method for treating viral disease | |
| SG11201408326TA (en) | Preparation method for perfluoro-2-methyl-3-pentanone and intermediate | |
| ZA201501558B (en) | Means and method for treating solid tumours | |
| EP2816126A4 (en) | Heat treatment method | |
| GB2519034B (en) | Authentication method and authentication program | |
| IL239654A0 (en) | Process for preparing 7beta-substituted 6alpha, 14alpha-ethenomorphinans and 7beta-substituted 6alpha, 14alpha-ethanomorphinans | |
| IL238331A0 (en) | Method for treating type 1 and type ii diabetes | |
| GB201213778D0 (en) | Process and dressng | |
| ZA201407215B (en) | Method for emulsion treatment | |
| PL2838903T3 (en) | Methods and compositions for treating viral infections | |
| GB201205449D0 (en) | Treatment process |